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In murine abdominal sepsis by colon ascendens stent peritonitis (CASP), a strong
increase in serum IgM and IgG antibodies was observed, which reachedmaximum values
14 days following sepsis induction. The specificity of this antibody response was studied
in serum and at the single cell level using a broad panel of bacterial, sepsis-unrelated as
well as self-antigens. Whereas an antibacterial IgM/IgG response was rarely observed,
studies at the single-cell level revealed that IgM antibodies, in particular, were largely
polyreactive. Interestingly, at least 16% of the IgM mAbs and 20% of the IgG mAbs
derived from post-septic mice showed specificity for oxidation-specific epitopes (OSEs),
which are known targets of the innate/adaptive immune response. This identifies those
self-antigens as the main target of B cell responses in sepsis.
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INTRODUCTION
Sepsis, by definition, is a life-threatening organ dysfunction caused by a dysregulated host response
to infection (1, 2), which is associated with high morbidity and mortality (3, 4). Due to an aging
population, a steady increase in surgical interventions, and the occurrence of antibiotic resistance,
sepsis is still of high clinical relevance (4–6).
B cells have been ascribed a protective function in sepsis which encompasses
antibody-dependent as well as -independent mechanisms (7, 8). However, during sepsis, a
large number of B cells and other immune cells are lost by apoptosis (9, 10) and it is assumed
that B cell responses are severely impaired (11, 12). In fact, Mohr et al. have shown that B cell
priming with defined antigens is defective in sepsis (13). By contrast, we and other research
groups have shown that sepsis induces high concentrations of serum IgM and IgG antibodies
of unknown specificities (13, 14). Since these may be responsible for the observed antibody-
mediated protection, we set out to examine their antigen specificities in a mouse model of
abdominal sepsis.
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During sepsis, the organism is flooded with bacterial antigens
as well as self-antigens, which are released by dying host
cells. Moreover, there is an abundance of danger signals, both
pathogen- and damage-associated molecular patterns (PAMPs
and DAMPs, respectively) (15, 16). These may, on the one
hand, act as adjuvants in an antigen-driven B cell response
and, on the other, trigger a polyclonal B cell reaction (17–
19). In addition to these danger signals, inflammation and
cell death are accompanied by lipid peroxidation, resulting in
the generation of oxidation-specific epitopes (OSEs), which are
also recognized by pattern recognition receptors (PRR) of the
innate immune system exerting an adjuvant effect (20–22).
All of these factors could contribute to the B cell response
in sepsis.
During sepsis, antibody production is induced by T cell-
dependent (TD) as well as -independent (TI) mechanisms (14).
In a TD immune reaction, follicular B cells are activated via
the B cell receptor. With the help of activated T cells, they
differentiate and form germinal centers, where class switch to
all Ig (sub)classes and somatic hypermutation take place. At the
end of this process, affinity-matured plasma cells have developed
that continuously secrete antibodies (23). TI B cell responses
may be triggered in two ways: TI-2 antigens like polysaccharides
efficiently crosslink B cell receptors and initiate a strong and
long-lasting antigen-specific primary response (24). In contrast,
TI-1 antigens like lipopolysaccharide (LPS) and bacterial DNA
(CpG) activate B cells polyclonally, i.e., independent of the B
cell receptor, via TLR triggering (25–27). Predominantly B-1-
and marginal zone (MZ) B cells can rapidly respond to TI-1
antigens (28).
The main reservoir of B-1 cells are the pleural and peritoneal
cavities, but a small proportion can be found in all lymphoid
organs. Not only are B-1 cells prone to TI responses, but
they are also the main producers of natural antibodies (NAbs),
defined as antibodies that circulate in normal individuals in
the absence of exogenous antigenic stimulation (29). NAbs are
considered polyreactive, usually lack somatic hypermutation and
are said to use a restricted set of B cell receptor genes (30–32).
NAbs are hence at the interface between innate and adaptive
immune responses, and can bridge the time gap until the TD
response has matured. In terms of their antigen specificity, B-1
cells are selected for a certain strength of self-antigen binding.
Remarkably, ∼30% of B-1 cell-derived IgM binds to OSEs. B-1
cells are able to switch to all IgG subclasses in vitro, whereas in
vivo, they are producers of NAbs, mainly of the IgM, IgG3, and
IgA isotype [reviewed extensively in (32–34)].
MZ B cells are located close to the marginal sinus in the
spleen, where they have direct access to blood-borne antigens
(35). Although they have the capacity to generate TD and TI
responses, their main function is the TI response against blood-
borne pathogens (36, 37). Very early in the course of an infection,
they differentiate to IgM- or IgG-secreting cells (38). Both TD
as well as TI processes take place during sepsis, and all B
cell populations become activated (8, 14). We have therefore
tested sepsis-induced IgM- and IgG-binding to a broad panel
of bacterial as well as autoantigens. OSE were identified as the
dominant target of the B cell response.
MATERIALS AND METHODS
Animals and Ethics Statement
All experiments were performed on 8–12 weeks old female
C57BL/6 wild type (WT) mice. All animals were housed in a
conventional, temperature-controlled animal facility with a 12-
h light and dark cycle, and provided with food and water ad-
libitum. All experiments were approved by the animal ethics
committee of the local animal protection authority (LALLF, State
Office for Agriculture, Food Safety and Fisheries Mecklenburg-
Western Pomerania; numbers LALLF M-V/TSD/7221.3-1.1-
052/07 and LALLF M-V/TSD/7221.3-1.2-013/09). All efforts
were made to minimize the suffering of mice.
CASP Surgery
CASP surgery was performed as described before (39, 40).
Briefly, mice were anesthetized with Ketamin (Ketanest, Parke-
Davis GmbH, Berlin) and xylazin (Rompun, Bayer Health Care,
Leverkusen) intraperitoneally (100 mg/10mg per kg bodyweight,
respectively) and a 18G stent (Ohmeda AB, Helsingborg,
Sweden) was implanted into their colon ascendens. Mice were
monitored every 4 h until recovery.
Hybridoma Generation
Splenocytes from mice 10 or 14 days following CASP or
sham surgeries were prepared and fused with X63 AG8.653
myeloma cells using polyethylene glycol (Sigma-Aldrich),
following an extensive protocol for fusion and selection
as described elsewhere (http://www.umass.edu/vetimm/docs/
Wagner_Hybridoma.pdf). Briefly, 10 million X63-cells were
fused with 1–3 × 107 splenocytes, and the fusion products were
plated in several dilutions into 96-well cell culture plates. Ten
days later, plates were screened under a light microscope for
hybridoma growth. Only hybridomas from plates where<50% of
the wells showed cell growth were taken into account, since this
improves the probability of monoclonality to over 85% (41). In
addition, wells were observed under a light microscope to select
for single clone growth based on morphology.
Immunohistochemical Autoantibody
Screening on HEp-2-Cells
Screening of autoantibodies was performed as described before
(13). Briefly, serum samples, diluted 1:100 in PBS containing
20% FCS or undiluted hybridoma supernatants were incubated
on HEp-2-ANA slides (INOVA Diagnostics, San Diego, CA,
USA) overnight at 4◦C. Slides were washed with PBS, and
bound antibodies were detected either with polyclonal goat anti-
mouse IgG or IgM conjugated to FITC (10µg/mL, Southern
Biotech, Atlanta, GA, USA). Slides were then equally exposed,
and pictures were taken with a Zeiss Axio imager A.1
fluorescence microscope (Zeiss, Göttingen, Germany) equipped
with Spotadvanced software (Diagnostic Instruments, Sterling
Heights, MI, USA) using the same settings for all images.
ELISA
Antigens were prepared for ELISA as follows: (i) Bacterial
antigens: Bacteria (E. coli, E. faecalis, P. mirabilis, S. aureus
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8325-4 1spa) were grown overnight in tryptic soy broth (TSB)
medium as described previously (41). Cells were washed twice
in cold PBS (3,340 g for 15min at 4◦C) and diluted to
an optical density at 595 nm (OD595) of 1.0 in PBS before
being inactivated by irradiation with UV-light for 10min;
(ii) Self-antigens: Histone H2A (calf thymus, 2µg/mL) and
dsDNA (calf thymus, 10µg/mL), both obtained from Sigma-
Aldrich, were diluted in PBS, whereas murine IgG-Fc-fragments
(Dianova, 1µg/mL) were diluted in coating buffer (pH 9.6;
Candor Bioscience GmbH, Wangen, Germany); (iii) LPS (E.
coli O55:B5, Sigma Aldrich, 10µg/mL) and sepsis unrelated
antigens, including TNP (14)-bovine serum albumin (BSA,
Biosearch Technologies, 10µg/mL) and ovalbumin (OVA,
Sigma-Aldrich, 10µg/mL) were diluted in coating buffer to the
indicated concentrations; (iv) OSEs: phosphocholine-conjugated
BSA (PC-BSA) was obtained from Biosearch Technologies
Inc. Malondialdehyde-acetaldehyde-modified BSA (MAA-BSA)
was prepared as described elsewhere (42). Human native
LDL was isolated, and Cu2+-oxidized LDL (CuOx-LDL) and
Malondialdehyde-modified LDL (MDA-LDL) were prepared as
described previously (42).
96-well flat-bottom microplates (Nunc MaxiSorpTM) were
coated with the respective antigens overnight at 4◦C (bacterial
antigens, H2A: 100 µL per well), LPS, dsDNA, murine IgG-
Fc-fragments and sepsis unrelated antigens: 50 µl per well).
The plates were then washed three times with PBS containing
0.05% Tween20, and blocked with PBS containing 10% fetal
calf serum (150 µL/◦) for 1 h at room temperature (RT).
Murine sera (dilution range 1:100–1:2,500) or hybridoma
supernatants were added to the wells and incubated for 90min
at RT. After three washing steps, bound antibodies were
detected using F(ab)2-fragments of goat anti-mouse IgG or
IgM conjugated to POD (Dianova) as previously described
(43). Chemiluminescence was measured using a Tecan Sunrise
photometer (Tecan Group Ltd., Maennedorf, Switzerland), and
the data were expressed as relative light units (RLU) per
100 ms.
RNA Isolation From Hybridoma Cells and
Complementary DNA Generation
Total RNA was isolated from about 1 × 105 hybridoma cells
using the RNeasy Mini Kit (QIAGEN GmbH, Hilden, Germany)
according to manufacturer’s instructions. The isolation steps
included a DNase-digestion step to eliminate genomic DNA.
The quantity of RNA was determined by using the DS-11 Series
Spectrophotometer (DeNovix Inc., DE, USA). One microgram
of RNA was transcribed to cDNA using oligo DT Primers of
the RevertAidTM First Strand cDNA Synthesis Kit (Fermentas)
as per the manufacturer’s instructions. For the amplification
of VH-domain sequences of the immunoglobulins, cDNA was
amplified by multiplex PCR using msVHE as universal forward
primer and a mixture of the Ig-specific reverse primers (Table 1).
The reaction was performed in a total volume of 25 µL using
2 µL of cDNA, 0.2 µL of GoTaq-polymerase (Promega), 2.5
µL of dNTP (1mM, Roche Diagnostics), 5 µL MgCl2 (25mM,
TABLE 1 | Primers used for VH-gene sequence amplification.
Primer
designation
Primer sequence References
Forward Primer:
msVHE 5′-GGGAATTCGAGGTGCAGCTGCAGGAGTCTGG-3′ (44)
Ig-Subclass-Specific Reverse Primers:
IgG1 5′-GATCCAGGGGCCAGTGGATAG-3′
IgG2b 5′-CACCCAGGGGCCAGTGGATAG-3′
IgG2c inner 5′-GCTCAGGGAAATAACCCTTGAC-3′ (45)
IgG3 inner 5′-GCTCAGGGAAGTAGCCTTTGAC-3′ (46)
IgM 5′-GGCTCTCGCAGGAGACGAGG-3′
Promega). Primers were used at a final concentration of 200 nM
each, and the PCR was performed for 35 cycles at 95◦C 30 s,
65◦C 30 s, 72◦C 45 s and a final elongation step at 72◦C for
10min. PCR products were analyzed on 1.5% agarose gels, and
the DNA bands of around 400 bp size were cut under UV
light for extraction of DNA using the Nucleo-Spin R© Extract II
kit (Machery-Nagel).
Cloning and Transformation of Target DNA
The extracted DNA-fragments were cloned into the pCR R© 2.1-
TOPO R© TA vector using the TOPO R© TA Cloning R© Kit (Life
Technologies, Thermo Fisher Scientific, Carlsbad, CA, USA).
All steps were done according to manufacturer’s instructions.
Products were transfected into chemically competent E. coli
by the heat-shock method. Transformed E. coli were cultivated
on LB agar plates containing 50µg/mL of each IPTG, x-
Gal and Ampicillin, and incubated at 37◦C for 12 h. At least
three single white colonies were picked and seeded further
into single wells of a 96-well plate containing LB agar with
50 µg/mL Ampicillin.
VH-N-DH-N-JH Fragment Sequencing and
Analysis
Plasmid isolation and sequencing of the single colonies
was performed by GATC Biotech AG, Konstanz, Germany,
using the vector-specific M13 forward primer. The resulting
sequences were further verified using IMGT/V-Quest
database, (https://www.imgt.org/IMGT_vquest/vquest?livret=0&
Option=mouseIg).
Statistical Analysis
Statistical analyses were performed using GraphPad Prism
6 (GraphPad software, San Diego, CA, USA). Data were
assessed for significant differences using One-Way ANOVA with
Bonferroni post test for selected pairs, or using the unpaired
Student t-test, whenever appropriate. P < 0.05 were considered
to be significant.
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RESULTS
A Strong Induction of Total Serum IgG
During Sepsis Was Not Due to an
Antibacterial IgG Response
We and others have shown that sepsis induced a marked increase
in serum IgM levels followed by an even stronger IgG response
(11, 13). As we have previously shown, most ASCs reside in the
spleen, and the class switch to IgG results from both TI and TD
processes (14). Since the antigen-specific T cell response is still
fully functional at the onset of sepsis (47), we assumed that the
class switched IgG response was mainly directed at the invasive
bacteria. To test this hypothesis, we induced sepsis in WT mice
using the CASP sepsis model. First, systemically disseminated
bacteria were identified by plating sera of septic mice onto
agar plates followed by microbiological identification of growing
colonies. Enterococcus faecalis (E. faecalis) and Escherichia coli
(E. coli), two microbial species of the intestinal flora, were
regularly found in the blood of septic mice. Antibody binding
to these bacteria as well as to Staphylococcus aureus (S. aureus),
which is often observed in the murine intestine, was then
measured by ELISA. UV-inactivated washed bacterial cells served
as antigens. To avoid non-specific IgG binding to S. aureus,
the protein A-deficient mutant strain 8425-1spa was used.
Additionally, LPS of E. coli was included. As shown in Figure 1,
sepsis induced a significant increase in IgM-binding to whole
bacteria as well as LPS. In contrast, there was no significant anti-
bacterial or anti-LPS IgG response in the majority of animals.
The absence of an anti-bacterial IgG response in sepsis was
in striking contrast to immunization with inactivated bacteria
(without adjuvant), where ímmunized animals did not develop
disease symptoms, but elaborated high specific antibacterial IgG
titres (Supplementary Figure 1). Thus, the very strong serum
IgG increase in sepsis was not due to an anti-IgG response to the
bacteria tested, namely S. aureus, E. coli and E. faecalis.
Sepsis-Induced Serum Antibodies Are
Directed Against Self-Antigens
In sepsis, the strong general IgG response with only a modest
reaction to bacterial antigens could be caused by polyclonal
activation of B-cells due to the release of large amounts of
PAMPs and DAMPs. We reasoned that autoreactive Ig should be
increased in this case, because the normal B-cell pool contains
numerous self-specificities (48–50). Moreover, the PAMPs and
DAMPs could also act as adjuvants in a TD immune response
to self-antigens that are released from damaged cells and tissues.
Therefore, we tested the sera of septic and control mice for Ig-
binding to eukaryotic cellular structures using HEp-2 cells as
antigens and FITC-labeled anti-mouse-IgM or IgG antibodies
for detection of binding. As shown in Figure 2, the sera of
septic mice (data from two representative septic animals are
depicted) showed an increase in autoreactive IgM and IgG
response, as compared to untreated animals (left panel), 14 days
after sepsis induction. The fluorescence patterns observed were
mostly diverse, where often more than one cellular structure was
stained (Figure 2, arrows). The binding patterns differed between
individual septic mice from the same cage. Hence, sepsis, which
was probably caused by very similar gut microbiota, induced
autoantibodies of different specificities. Remarkably, a similar
autoreactive response was observed in the sera of splenectomized
animals upon sepsis induction (Supplementary Figure 2).
Sepsis Increased Serum Antibodies
Directed Against Sepsis-Unrelated
Antigens
An immune response which is largely polyclonal rather than
antigen-driven would be expected to show increased antibody
binding to antigens unrelated to sepsis. Hence, besides anti-
bacterial and self-binding antibodies, we screened for the
presence of antibodies binding to such sepsis-unrelated antigens.
At first, we investigated the binding of serum antibodies
to two antigens the animals had never been exposed to,
namely the classical TD protein antigen ovalbumin (OVA)
and the hapten 2,4,6-trinitrophenyl (TNP) conjugated to
bovine serum albumin (TNP-(14)-BSA). Regarding OVA, only
IgM binding increased significantly during sepsis (data not
shown), whereas IgM- as well as IgG-binding to TNP-(14)-BSA
were both very strongly enhanced (Supplementary Figure 3).
Together, these results clearly support the concept of a
polyclonal B cell response, which may be dominated by
NAb specificities.
Sepsis Induced High Titer IgM and IgG
Antibodies Directed Against
Oxidation-Specific Epitopes (OSEs)
Since sepsis induced a robust autoreactive-antibody response,
we questioned whether these antibodies would be able to bind
to OSEs, which are present at high density on apoptotic cells,
whose numbers are known to increase during sepsis. OSEs
generated during sepsis act as an endogenous DAMPs, and
initiate an innate immune response. It has been shown that a
large proportion of NAbs, especially those produced by B-1 cells,
bind to OSEs (20, 42). Therefore, we tested sera of septic and
untreated animals at day 10 and 14 for OSE-specific antibodies
by chemiluminescent ELISA. Sepsis elicited a very strong IgM
and IgG response to known OSEs in all tested animals (Figure 3
and Supplementary Figure 4), while there were very low levels
of OSE-specific antibodies or none at all in untreated animals.
Hence, at day 14 post sepsis, the IgM response to both modified
LDL and BSA was significantly higher in septic mice than in the
control group, where specific IgMwas low or even under the limit
of detection (Figure 3). On the same day, the IgG/IgM response
to MAA-BSA was 4-fold higher than in the untreated group. The
IgM response to CuOx-LDL showed a trend toward increased
levels, while IgG levels were significantly higher compared
to untreated animals (Supplementary Figure 4). Since under
other conditions, such as hypercholesterolemia, IgM antibodies
dominate the immune response to OSEs (51), the pronounced
specific class-switched response in sepsis is remarkable.
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FIGURE 1 | Binding of sera IgM/IgG to bacteria and LPS. The binding of murine serum antibodies, IgM (A-D) or IgG (E-H), to indicated bacteria; E. coli (A,C),
E. faecalis (B,F), S. aureus (C,G), and LPS (D,H) was tested by ELISA. Fourteen days after sepsis induction, blood was collected, and sera were diluted 1:100 in
blocking buffer. Sera from non-septic animals were used as controls. Control mice were untreated (•), whereas the treated mice were anesthetized only (N), or
additionally received a laparotomy ( ), or sham surgery (△). Mice that underwent CASP surgery are indicated by a black diamond (). Mean values of OD 450 nm are
shown. Each symbol represents one animal (N = 5–18). Statistical analysis was done by One-way ANOVA with the Bonferroni post test for selected pairs. *p < 0.05,
**p < 0.01, ***p < 0.001.
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FIGURE 2 | Serum antibodies directed against self-antigens 14 days after sepsis induction. Sepsis was induced in C57BL/6 mice by 18G CASP. Control mice
remained untreated. Fourteen days later blood was taken, and sera diluted 1:100 in 20% FCS/PBS were incubated on HEp-2-ANA slides. Bound antibodies were
detected by FITC-labeled anti-mouse IgM or IgG antibodies. Out of the tested serum antibodies, 12/13 IgM and 12/13 IgG antibodies were autoreactive. Shown are
representative pictures of septic and control mice. N = 8 per group. Serum IgM and IgG binding patterns varied greatly. In most cases more than one cellular structure
is stained, albeit at variable intensities.
Studies at the Single Cell Level Revealed a
High Proportion of Autoreactive IgM
Antibodies
To study the sepsis-induced antibodies at a single-cell level,
monoclonal antibodies (mAbs) were generated. Since we
discovered the spleen as the main source of antibody secreting
cells (ASCs) in sepsis (14), splenocytes from eight septic mice
were obtained on day 10 after sepsis induction and fused. Three
quarters (74.3%) of the hybridomas from septic mice produced
IgM (Table 2). However, sepsis induced a much stronger increase
in serum IgG than IgM, which peaked at day 14 (14). Assuming
that the class switch to IgG may not have been completed on
day 10 after sepsis induction, additional fusions were performed
using splenocytes from six septic mice on day 14. However,
choosing this later time point did not change the proportion
of IgM- to IgG-producing cells, where 82% of the resulting
hybridomas secreted IgM (Table 2). Several attempts to produce
hybridomas from non-septic control mice failed, presumably
due to the lack of activated B cells and plasmablasts in the
spleen, which is a limitation of this study (data not shown).
Determination of the mAb specificities confirmed and extended
the observations made with serum antibodies, namely that sepsis
induces autoreactive antibodies, predominantly IgM.
The total of 386 hybridoma supernatants derived from the
14 above mentioned septic mice and containing either IgM or
IgG mAbs were screened for autoreactivity. A large proportion
of IgM mAbs (31% to 40%) reacted with specific structures
of the HEp-2 cells (Table 2). HEp-2-binding IgM mAbs were
found in every animal, regardless of whether the spleen cells
were obtained 10 or 14 days after sepsis. In contrast, only
three out of 93 IgG mAbs showed detectable HEp-2-binding,
when using undiluted hybridoma culture supernatants. These
auto-reactive IgG hybridomas were obtained from three mice.
Figure 4 illustrates the variability of the binding patterns of the
mAbs derived from splenic B cells of septic mice 10 or 14 days
after CASP induction, which bind several cellular self-antigens.
FITC-labeled anti-mouse IgG or IgM antibodies were used to
determine the binding of those mAbs and clearly showed that,
similar to our previous experiment at the serum level, the binding
patterns of the individual antibodies were highly variable.
Most IgM Antibodies Are Polyreactive
Since we observed high titres of autoantibodies in sera of septic
mice at day 10 or 14 (Figure 2), we wondered whether this also
applies to the mAbs present in the hybridoma supernatants of six
septic mice (generated from splenocytes at day 10 of sepsis).
We tested the hybridoma supernatants for mAb-binding to
a broad panel of antigens, including bacterial and self-antigens,
as well as two antigens that the animals had never been exposed
to, namely TNP and OVA. Binding was observed with 27 out of
120 IgM-supernatants (22.5%) (Table 3) but with none of the 40
tested IgG supernatants (data not shown). The majority of the
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FIGURE 3 | Serum IgM and IgG binding to model oxidation-specific epitopes. C57BL/6 mice were subjected to CASP surgery, while control animals remained
untreated. Ten and 14 days after sepsis induction, blood was drawn to determine serum IgM and IgG binding to malondialdehyde-modified LDL [MDA-LDL; (A)] and
phosphocholine-conjugated BSA [PC-BSA; (B)], using chemiluminescent ELISA. Serum dilutions used are indicated in brackets. Statistical analysis was performed
using the unpaired t-test. N = 3–9 per group. *p < 0.05, **p < 0.01, ***p < 0.001.
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binding IgM mAbs (85%) were polyreactive, recognizing at least
two antigens in the test panel used.
In Septic Mice, a Large Proportion of
mAbs, Both IgM and IgG, Binds to
Oxidation Specific Epitopes
Eighteen IgM mAbs that showed reactivity to the antigen panel
in Table 3, as well as all available IgG mAbs (N = 20) of so far
TABLE 2 | HEp-2-positive IgM- or IgG-secreting hybridomas.
HEp-2-positive hybridoma supernatants
IgM IgG
N/total % N/total %
CASP d10 91/225 40 3/78 4
CASP d14 21/68 31 0/15 0
The table shows the numbers of IgM or IgG hybridoma supernatants binding to
cellular structures of HEp-2 cells, respective to the total numbers of tested hybridomas.
Splenocytes were obtained on day 10 (eight animals, eight fusions) or 14 (six animals,
seven fusions) after sepsis induction.
unknown specificity, were tested for binding to OSEs. Thirteen
(72%) IgM and 5 (25%) IgG mAbs showed binding to one or
several OSEs in ELISA (Table 4). Examples of IgG mAb titration
curves are shown in the Supplementary Figure 5. The five OSE-
specific IgG hybridomas were derived from four different mice.
Remarkably, with the exception of IgG3, the OSE-specific mAbs
encompassed all IgG subclasses. These findings underline that
OSEs are prominent targets of the humoral immune response
in sepsis.
Most Sepsis-Induced IgG mAbs Carried
Few Somatic Mutations
Many class switched antibody responses are TD and are
characterized by somatic hypermutation. Therefore, the IgG
mAbs were tested for somatic hypermutation by sequencing
the variable domains of the IgG heavy chains. IgG mAbs
at day 10 or 14 after sepsis mostly showed no significant
differences in mutations (Supplementary Figure 6A). Most
sequences were near germline, similar to 12 IgG monoclonal
antibodies obtained from an untreated animal, which all
had <4 mutations/100 nucleotides (Supplementary Figure 6A).
However, four out of the 34 IgG mAbs derived from septic
animals had five or more mutations per 100 nucleotides,
FIGURE 4 | Monoclonal antibodies derived from splenic B cells of septic mice bind several cellular self-antigens. Ten or 14 days after CASP induction, splenocytes
were isolated and fused with myeloma cells to obtain hybridomas. Supernatants of monoclonal IgM- or IgG-producing hybridomas were incubated on HEp-2-ANA
slides to detect auto-reactivity. Bound IgG or IgM was detected by FITC-labeled anti-mouse IgG or IgM antibodies. Three examples, respectively, of autoreactive
monoclonal IgM- and IgG-antibodies are shown. The binding patterns of the various antibodies showed obvious differences, where in most cases more than one
cellular structure was stained, albeit at varying intensities (indicated by arrows). For quantified data, regarding the numbers/percent of IgM or IgG hybridoma
supernatants from septic mice directed against self-antigens, please refer to Table 2.
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TABLE 3 | Antigen-binding patterns of positively-tested IgM hybridomas.
Positive clones Bacterial antigens Foreign antigens Self antigens
E. coli P. mirabilis S. aureus LPS (E. coli) TNP-BSA OVA ds DNA histone HIIA IgG-Fc HEp-2-Test
1 F4_03 + + /
2 F4_04 + +
3 F4_05 + + + + + +
4 F4_09 + + +
5 F4_16 + + + + +
6 F4_23 + + + + + + + + + +
7 F4_38 + + + +
8 F4_46 + +
9 F4_55 + /
10 F5_10 + +
11 F5_11 + + + +
12 F5_17 + + +
13 F6_20 +
14 F7_07 + +
15 F7_30 + +
16 F7_32 + +
17 F7_33 + +
18 F7_36 + +
19 F7_39 +
20 F8_14 + + +
21 F9_09 + + +
22 F9_10 + + + +
23 F9_12 + + + /
24 F9_24 + + + +
25 F9_29 + +
26 F9_33 +
27 F9_38 + + + + +
Overview of the antigen binding patterns of 27 binding (out of a total of 120 tested) IgM hybridoma-supernatants. The hybridomas were generated from splenocytes of septic mice at
day 10 and tested for binding to a panel of bacterial, sepsis-unrelated (foreign) as well as self-antigens by ELISA. Binding to HEp-2 cells was tested by fluorescence microscopy. (+,
binding; /, not tested). The corresponding OD (450 nm) values are shown in Supplementary Table 1.
indicative of somatic hypermutation. As such mAbs were
present already at day 10, they were probably derived from
memory B cells (52). OSE-specific and –non-specific IgG mAbs
showed similar proportions of highly mutated IgG (Figure 5).
Thus, most of the IgG antibodies generated during sepsis used
near-germline gene sequences. Regarding the CDR3 length,
the number of amino acid exchanges per V-region as well
as the proportion of non-silent mutations, there were no
significant differences between septic and non-septic animals
(Supplementary Figures 6, 7).
DISCUSSION
Our data clearly show that OSEs are the main targets of the
strong humoral immune response observed in sepsis. While Ig
binding patterns to other self-epitopes were individual, OSE-
specific binding was observed in all tested animals.
The sepsis-induced suppression of the adaptive immune
system is well-documented (10, 13, 53). Nevertheless, we and
others observed a strong increase in serum IgM and IgG
concentrations following sepsis (13, 14). Interestingly, the peak of
the IgG serum concentration exceeded that of IgM by a factor of
four, and an Ig switching to all IgG subclasses was seen. However,
at the single cell level, there were three times as many IgM
hybridomas as those producing IgG. Although one could argue
that fusion was performed too soon, we found essentially the
same proportions on day 14 as on day 10, which rules out time
as the causal factor. Although the numbers of hybridomas are
in general too low to make a definitive conclusion, a plausible
explanation for this observation may be found in the half-lives
of IgM vs. IgG antibodies. IgM has a markedly shorter serum
half-life than IgG, and the half-life of polyreactive IgM is further
reduced by Ag-binding, leading to a relative accumulation of
IgG (54, 55).
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TABLE 4 | Binding pattern of CASP d10 monoclonal IgG and IgM to
oxidation-specific epitopes.
Clone Ig-class Binding specificity
Oxidation-specific epitopes (OSE) Human native LDL
MAA-BSA MDA-/CuOx-LDL PC-BSA
F4_32 IgG1 × × ND -
F6_13 IgG2b × × - -
F8_07 IgG2c × × × ×
F9_3_H7 IgG1 × × ND -
F9_25 IgG2c × × - -
F4_38 IgM × × - -
F5_10 IgM × × × -
F7_07 IgM × × - -
F9_24 IgM × × - -
F9_38 IgM × × × -
F4_04 IgM × × - -
F4_16 IgM × × - -
F4_46 IgM × - - -
F7_32 IgM × × - -
F9_09 IgM × - - -
F9_29 IgM × × - -
F8_14 IgM × × × ×
F9_10 IgM × × × ×
F7_33 IgM - - - ×
F4_09 IgM - - - -
F7_36 IgM - - - -
F7_39 IgM - - - -
F9_12 IgM - - - -
The hybridomas were generated from splenocytes of septic mice at day 10. Twenty IgG
hybridoma-supernatants (diluted to 0.25µg/mL) and 18 IgM hybridoma-supernatants
(diluted to 0.125µg/mL) were tested for binding to model oxidation-specific epitopes.
Human native LDL served as control. Binding specificities of five positively-tested IgG, as
well as all IgM clones, are shown. ×, binding; -, no binding; MAA-BSA, malondialdehyde-
acetaldehyde-modified bovine serum albumin (BSA); MDA/CuOx-LDL, malondialdehyde-
modifed (MDA)/Cu2+-oxidized (CuOx)-LDL; PC-BSA, phosphorylcholine conjugated to
BSA; ND, not determined.
Since sepsis induces dissemination of endogenous bacteria
into the bloodstream (11), a specific antibacterial IgG response
would have been expected. However, there was very little serum
IgG binding to bacteria in post-septic mice. Since we focussed
our investigation on culturable bacteria in the sera of septic
mice, it is possible that bacterial species other than the ones
examined here were the culprits, since ELISA was performed
only for E. coli, S. aureus, and E. faecalis. However, E. coli
and E. faecalis originate from the serum of a septic animal. In
fact, the bacterial strains used for testing are definitely present
in large numbers in the intestine. When animals were injected
i.p. with dead bacteria (E. coli, S. aureus, and E. faecalis)
without sepsis, they were perfectly able to elaborate a specific
IgG response. Depending on the bacterial species, we could
show that 107-109 UV-inactivated bacteria trigger a robust
specific IgG response (Supplementary Figure 1). Hence, we
assume that sepsis interferes with an antibacterial antibody
FIGURE 5 | Number of mutations in Vh-genes of monoclonal IgG. CASP
surgery was performed on C57BL/6 mice. Hybridomas were generated by
fusing splenocytes from 10- days-septic mice. The resultant monoclonal IgG
hybridomas were sequenced for Vh-genes. Mutations of monoclonal IgG that
showed binding to OSEs (OSE pos.) were compared to IgG that showed no
binding (OSE neg.). Statistical analysis was performed using the unpaired
t-test. N = 5–14 per group. nt, nucleotides; ns, not significant.
response. Interestingly enough, we rather observed Ig binding to
autoantigens, as well as antigens, to which the animals had never
been exposed. The production of natural autoantibodies against
a spectrum of autoantigens has been described in sepsis patients
(56–58). Using a relatively small panel of autoantigens, Burbelo
et al. detected autoantibodies in 46% of severe sepsis patients,
suggesting that this is a relatively common phenomenon (58).
However, the production of autoantibodies is not confined to
sepsis, but appears to be a general phenomenon observed with
other types of bacterial, viral, and protozoan infections (18, 59–
61), in addition to autoimmune disorders. In their recent study,
Sakakibara et al. observed that the immune response to murine
γ-herpesvirus 68 is accompanied by autoantibody production
from polyreactive B cells in the germinal center, whose self-
reactivity is generated through somatic hypermutation (61).
More interestingly, several reports suggest a role of polyclonal
activation in triggering anti-self responses, and hence leading to
autoimmune disorders as a consequence of infections (18, 62).
For instance, a direct link between infection and autoimmune
encephalitis has been experimentally demonstrated in mice, and
has been attributed to the production of autoantibodies (62).
It has been demonstrated that sepsis induces massive
apoptosis of B and T lymphocytes, as well as DCs in mice and
humans, and the release of danger molecules, known as PAMPs
and DAMPs (8, 9, 63–67). We confirmed this in our model by
TUNEL staining (terminal deoxynucleotidyl transferase dUTP
nick end labeling) of the spleens for apoptotic nuclei (data not
shown). The observed autoantigen response in sepsis could be
explained by a polyclonal B cell activation through PAMPs and
DAMPs, which activate B cells independent of the BCR, leading
to the production of the so-called NAbs, which are polyreactive
(68). To test whether polyreactive (natural) Abs or monoreactive
Ig from a large variety of B cells dominate the humoral immune
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response after sepsis, an analysis at the single cell level was
conducted. It revealed that a large proportion of IgM-producing
cells were polyreactive, as one would have expected based on the
results obtained with serum.
Our results identify OSEs as the dominant target of the B
cell response in murine polymicrobial sepsis: First, all post-
septic animals had OSE-binding IgM and IgG, whereas antibody
binding patterns to other tested autoantigens differed between
individuals, even from the same cage. Second, anti-OSE titres
were much higher than those of other tested bacterial or
self-antigens. Finally, OSE-specific B cells were very frequent.
Thirteen out of 18 tested IgM mAbs bound to OSEs even at
low concentrations. Since 19% (23/120) of the IgM mAbs were
polyreactive, at least 14% of IgM-producing B cells were OSE-
specific. This frequency is somewhat similar to that of IgG mAbs,
of which 25% were OSE-reactive.
Several points argue for a B-1 cell-driven immune response
in the case of IgM. B-1 cells reside in the peritoneum and
upon activation migrate to the spleen as well as other lymphatic
organs, where they differentiate into ASCs (69, 70). These are
the main producers of NAbs, which are polyreactive and utilize
germline-near sequences (68). Chou et al. have shown that 20–
30% of B-1 cell-derived IgM targets model-OSEs (42). This
reflects the frequencies we find in monoclonal IgM and IgG.
Moreover, Chang et al. have demonstrated that immunization of
mice with apoptotic cells, which are abundant in sepsis, induces
OSE-binding IgM (70).
In contrast, it is rather unlikely that the IgG response to
OSEs is also dominated by B-1 cells. In B-1 cells, only a switch
to IgG3 has been shown in vivo (31, 71). However, none of
the five OSE-specific IgG mAbs were IgG3, whereas all other
IgG subclasses were represented. Hence, a TD response of
follicular B cells appears more likely. Chang et al. were able to
induce OSE-binding IgG in mice by immunizing with model-
OSE and apoptotic cells simultaneously (70). Moreover, Grasset
et al. showed that some follicular B cells can bind fluorescently-
labeled oxidized LDL. Repeated immunization with apoptotic
cells induced OSE-binding IgG (72).
We suggest the following model: In sepsis, numerous immune
cells undergo apoptosis. PAMPs and DAMPs polyclonally
activate peritoneal B-1 cells to migrate to the spleen and
differentiate into ASCs. These produce NAbs, explaining the
increase in serum IgM targeting OSEs as well as other
autoantigens. NAbs, including OSE-targeting IgM antibodies,
may act as scavengers, promoting the clearance of apoptotic
cells and debris, which would be relevant in sepsis (22, 42). In
this study, however, we observed that OSE-specific antibodies
had switched to IgG as well, presumably in a TD response. It
may be speculated that the dominant response to OSEs restricts
a specific antibody response to the sepsis-causing bacteria,
which the organism would mount in the absence of apoptosis.
Besides this, massive apoptosis has been shown to be tolerogenic,
which explains the well-known fact that sepsis does not induce
strong protective immune memory (11). The pathophysiological
function of OSEs and OSE-specific IgM and IgG in sepsis
should now be investigated, to determine whether OSE-specific
antibodies could have therapeutic potential.
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